Anika Therapeutics | Betriebsergebnis





Betriebsergebnis Veränderung Datum
Abbott USD 2.25B 73M 2025-12
Agenus USD -13.31M 12.58M 2025-03
Agios Pharmaceuticals USD -116.87M 10.19M 2025-09
Anika Therapeutics USD -4.28M 32.1M 2025-03
Arrowhead Research USD 40.81M 3.3M 2025-12
Enanta Pharmaceuticals USD -23.54M 98.15M 2024-12
Halozyme Therapeutics USD 217.92M 15.48M 2025-09
Heron Therapeutics USD -5.66M 782K 2024-09
Insmed USD -261.35M 7.48M 2025-09
Integra LifeSciences USD 11.76M 13.07M 2025-09
Intrexon USD -60.84M 26.62M 2024-06
J&J USD 5.59B 1.81B 2025-12
Karyopharm Therapeutics USD -31.28M 5M 2024-12
Ligand Pharmaceuticals USD 158.89M 149.17M 2025-09
MacroGenics USD 18.64M 55.4M 2025-09
Merit Medical Systems USD 42.61M 4.41M 2025-09
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 1.7B 2.17B 2025-12
Smith & Nephew USD 440M 50M 2025-12
Stryker USD 1.97B 609M 2025-12
Surmodics USD -5.64M 276K 2024-09
Veracyte USD 23.11M 8.8M 2025-09
Xencor USD -47.52M 14.35M 2025-09
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12


Anika Therapeutics Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.